Changes

Jump to: navigation, search

B-cell acute lymphoblastic leukemia - historical

790 bytes added, 23:39, 28 December 2018
m
L-Asparaginase, Vincristine, Prednisone {{#subobject:d039d8|Regimen=1}}
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_Prednisone|Daunorubicin, L-Asparaginase, Vincristine, Prednisone]]
|style="background-color:#ffffbf"|Seems not superior
|-
|[http://ascopubs.org/doi/abs/10.1200/JCO.1993.11.3.527 Tubergen et al. 1993 (CCG-105)]
|style="background-color:#1a9851"|Phase III (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_Prednisone|Daunorubicin, L-Asparaginase, Vincristine, Prednisone]]
|style="background-color:#d3d3d3"|Not reported
|-
|[http://www.bloodjournal.org/content/101/10/3809.long Bostrom et al. 2003 (CCG-1922)]
# '''DCLSG ALL V:''' van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V); A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). Am J Pediatr Hematol Oncol. 1989 Summer;11(2):125-33. [https://www.ncbi.nlm.nih.gov/pubmed/2665546 PubMed]
# '''MRC UKALL VIII:''' Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol. 1991 Jun;78(2):187-96. [https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.1991.tb04415.x link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/2064956 PubMed]
# '''CCG-105:''' Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol. 1993 Mar;11(3):527-37. [http://ascopubs.org/doi/abs/10.1200/JCO.1993.11.3.527 link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/8445428 PubMed]
# '''CCG-1922:''' Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME; Children's Cancer Group. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003 May 15;101(10):3809-17. Epub 2003 Jan 16. [http://www.bloodjournal.org/content/101/10/3809.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/12531809 PubMed]
LookupUsers, editors, emailconfirmed
24,569
edits

Navigation menu